A comprehensive view of Over-the-Counter (OTC) Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
CA AB82: Dietary supplements for weight loss and over-the-counter diet pills.
Published:
May 01, 2024
by California 2023-2024 Session
|
J&J spinoff Kenvue, maker of Benadryl, Tylenol, other OTC products, to open a new headquarters in Summit, New Jersey with over 3,000 employees; the facility to include offices, research and development centers and an innovation lab on the 46-acre campus
Published:
April 26, 2024
by The Record
|
Cardinal Health recalls one lot of Curity Flexible Adhesive Bandage in Canada due to potential latex contamination; other lots and SKUs remain unaffected
Published:
April 25, 2024
by Contify Life Science News
|
Bayer launches Iberogast in the US, a plant-based digestive relief product developed after more than six decades of research; the proprietary blend is clinically proven to alleviate common digestive symptoms and is available on Amazon and major retailers
Published:
April 24, 2024
by Bayer AG
|
Cardinal Health to build a new 350,000-square-foot DC in central Ohio to expand its distribution capacity for OTC products, creating around 100 jobs by summer 2025; this will be Cardinal Health's fourth distribution facility in the region
Published:
April 02, 2024
by Columbus Dispatch (OH)
|
Ask us about our R&D/Patents market view